APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cell Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Stem Cell Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025182 pages

Choose your research edition.

Industry ResearchStem Cell Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cell Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Stem Cell Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cell Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cell Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Stem Cell Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Stem Cell Drugs include Anterogen, Chiesi Pharmaceuticals, CORESTEM, Inc, JCR Pharmaceuticals Co., Ltd, MEDIPOST, New York Blood Center, Pharmicell Co., Ltd and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Stem Cell Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Stem Cell Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Stem Cell Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Stem Cell Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Stem Cell Drugs Segment by Company

Anterogen

Chiesi Pharmaceuticals

CORESTEM, Inc

JCR Pharmaceuticals Co., Ltd

MEDIPOST

New York Blood Center

Pharmicell Co., Ltd

Takeda

Stem Cell Drugs Segment by Type

Adipose-Derived

Cord Blood-Derived

Bone Marrow-Derived

Others

Stem Cell Drugs Segment by Application

Osteoarthritis

Amyotrophic Lateral Sclerosis

Acute Graft-versus-Host Disease

Crohn’s Disease

Others

Stem Cell Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Stem Cell Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Stem Cell Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Stem Cell Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Stem Cell Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Stem Cell Drugs Industry Trends Table 2. Stem Cell Drugs Industry Drivers Table 3. Stem Cell Drugs Industry Opportunities and Challenges Table 4. Stem Cell Drugs Industry Restraints Table 5. Global Stem Cell Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Stem Cell Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Stem Cell Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Stem Cell Drugs Sales Market Share by Manufacturers Table 9. Global Stem Cell Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Stem Cell Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Stem Cell Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Stem Cell Drugs Manufacturers, Product Type & Application Table 13. Global Stem Cell Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Stem Cell Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Adipose-Derived Table 17. Major Manufacturers of Cord Blood-Derived Table 18. Major Manufacturers of Bone Marrow-Derived Table 19. Major Manufacturers of Others Table 20. Global Stem Cell Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 22. Global Stem Cell Drugs Sales by Type (2027-2032) & (K Units) Table 23. Global Stem Cell Drugs Sales Market Share by Type (2021-2026) Table 24. Global Stem Cell Drugs Sales Market Share by Type (2027-2032) Table 25. Global Stem Cell Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Stem Cell Drugs Revenue by Type (2021-2026) & (K Units) Table 27. Global Stem Cell Drugs Revenue by Type (2027-2032) & (K Units) Table 28. Global Stem Cell Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Stem Cell Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Osteoarthritis Table 31. Major Manufacturers of Amyotrophic Lateral Sclerosis Table 32. Major Manufacturers of Acute Graft-versus-Host Disease Table 33. Major Manufacturers of Crohn’s Disease Table 34. Major Manufacturers of Others Table 35. Global Stem Cell Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 37. Global Stem Cell Drugs Sales by Application (2027-2032) & (K Units) Table 38. Global Stem Cell Drugs Sales Market Share by Application (2021-2026) Table 39. Global Stem Cell Drugs Sales Market Share by Application (2027-2032) Table 40. Global Stem Cell Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Stem Cell Drugs Revenue by Application (2021-2026) & (K Units) Table 42. Global Stem Cell Drugs Revenue by Application (2027-2032) & (K Units) Table 43. Global Stem Cell Drugs Revenue Market Share by Application (2021-2026) Table 44. Global Stem Cell Drugs Revenue Market Share by Application (2027-2032) Table 45. Global Stem Cell Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Stem Cell Drugs Sales by Region (2021-2026) & (K Units) Table 47. Global Stem Cell Drugs Sales Market Share by Region (2021-2026) Table 48. Global Stem Cell Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Stem Cell Drugs Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 52. North America Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 53. Europe Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 55. Europe Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Stem Cell Drugs Sales by Country (2027-2032) & (K Units) Table 62. Global Stem Cell Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Stem Cell Drugs Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Stem Cell Drugs Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Stem Cell Drugs Revenue Market Share by Region (2021-2026) Table 66. Global Stem Cell Drugs Revenue Market Share by Region (2027-2032) Table 67. Anterogen Company Information Table 68. Anterogen Business Overview Table 69. Anterogen Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Anterogen Stem Cell Drugs Product Portfolio Table 71. Anterogen Recent Development Table 72. Chiesi Pharmaceuticals Company Information Table 73. Chiesi Pharmaceuticals Business Overview Table 74. Chiesi Pharmaceuticals Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Chiesi Pharmaceuticals Stem Cell Drugs Product Portfolio Table 76. Chiesi Pharmaceuticals Recent Development Table 77. CORESTEM, Inc Company Information Table 78. CORESTEM, Inc Business Overview Table 79. CORESTEM, Inc Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. CORESTEM, Inc Stem Cell Drugs Product Portfolio Table 81. CORESTEM, Inc Recent Development Table 82. JCR Pharmaceuticals Co., Ltd Company Information Table 83. JCR Pharmaceuticals Co., Ltd Business Overview Table 84. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Product Portfolio Table 86. JCR Pharmaceuticals Co., Ltd Recent Development Table 87. MEDIPOST Company Information Table 88. MEDIPOST Business Overview Table 89. MEDIPOST Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. MEDIPOST Stem Cell Drugs Product Portfolio Table 91. MEDIPOST Recent Development Table 92. New York Blood Center Company Information Table 93. New York Blood Center Business Overview Table 94. New York Blood Center Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. New York Blood Center Stem Cell Drugs Product Portfolio Table 96. New York Blood Center Recent Development Table 97. Pharmicell Co., Ltd Company Information Table 98. Pharmicell Co., Ltd Business Overview Table 99. Pharmicell Co., Ltd Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Pharmicell Co., Ltd Stem Cell Drugs Product Portfolio Table 101. Pharmicell Co., Ltd Recent Development Table 102. Takeda Company Information Table 103. Takeda Business Overview Table 104. Takeda Stem Cell Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Takeda Stem Cell Drugs Product Portfolio Table 106. Takeda Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Stem Cell Drugs Distributors List Table 110. Stem Cell Drugs Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Stem Cell Drugs Product Image Figure 2. Global Stem Cell Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stem Cell Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Stem Cell Drugs Sales (2021-2032) & (K Units) Figure 5. Global Stem Cell Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Stem Cell Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Adipose-Derived Image Figure 9. Cord Blood-Derived Image Figure 10. Bone Marrow-Derived Image Figure 11. Others Image Figure 12. Global Stem Cell Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Stem Cell Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Stem Cell Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Stem Cell Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Stem Cell Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Stem Cell Drugs Revenue Market Share by Type (2021-2032) Figure 18. Osteoarthritis Image Figure 19. Amyotrophic Lateral Sclerosis Image Figure 20. Acute Graft-versus-Host Disease Image Figure 21. Crohn’s Disease Image Figure 22. Others Image Figure 23. Global Stem Cell Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Stem Cell Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Stem Cell Drugs Sales Market Share by Application (2021-2032) Figure 26. Global Stem Cell Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Stem Cell Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Stem Cell Drugs Revenue Market Share by Application (2021-2032) Figure 29. North America Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 31. U.S. Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 36. Germany Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 43. China Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Stem Cell Drugs Sales Market Share by Country (2021-2032) Figure 51. Brazil Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Stem Cell Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Stem Cell Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Stem Cell Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 62. North America Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Europe Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Stem Cell Drugs Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Stem Cell Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Stem Cell Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Adipose-Derived
  • Cord Blood-Derived
  • Bone Marrow-Derived
  • Others
Applications
  • Osteoarthritis
  • Amyotrophic Lateral Sclerosis
  • Acute Graft-versus-Host Disease
  • Crohn’s Disease
  • Others
Companies covered
  • Anterogen
  • Chiesi Pharmaceuticals
  • CORESTEM, Inc
  • JCR Pharmaceuticals Co., Ltd
  • MEDIPOST
  • New York Blood Center
  • Pharmicell Co., Ltd
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Stem Cell Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Stem Cell Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Stem Cell Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Stem Cell Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Stem Cell Drugs Market Dynamics
  1. 2.1 Stem Cell Drugs Industry Trends
  2. 2.2 Stem Cell Drugs Industry Drivers
  3. 2.3 Stem Cell Drugs Industry Opportunities and Challenges
  4. 2.4 Stem Cell Drugs Industry Restraints
3 Stem Cell Drugs Market by Manufacturers
  1. 3.1 Global Stem Cell Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Stem Cell Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Stem Cell Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Stem Cell Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Stem Cell Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Stem Cell Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Stem Cell Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Stem Cell Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Stem Cell Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Stem Cell Drugs Tier 1, Tier 2, and Tier 3
4 Stem Cell Drugs Market by Type
  1. 4.1 Stem Cell Drugs Type Introduction
  2. 4.1.1 Adipose-Derived
  3. 4.1.2 Cord Blood-Derived
  4. 4.1.3 Bone Marrow-Derived
  5. 4.1.4 Others
  6. 4.2 Global Stem Cell Drugs Sales by Type
  7. 4.2.1 Global Stem Cell Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Stem Cell Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Stem Cell Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Stem Cell Drugs Revenue by Type
  11. 4.3.1 Global Stem Cell Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Stem Cell Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Stem Cell Drugs Revenue Market Share by Type (2021-2032)
5 Stem Cell Drugs Market by Application
  1. 5.1 Stem Cell Drugs Application Introduction
  2. 5.1.1 Osteoarthritis
  3. 5.1.2 Amyotrophic Lateral Sclerosis
  4. 5.1.3 Acute Graft-versus-Host Disease
  5. 5.1.4 Crohn’s Disease
  6. 5.1.5 Others
  7. 5.2 Global Stem Cell Drugs Sales by Application
  8. 5.2.1 Global Stem Cell Drugs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Stem Cell Drugs Sales by Application (2021-2032)
  10. 5.2.3 Global Stem Cell Drugs Sales Market Share by Application (2021-2032)
  11. 5.3 Global Stem Cell Drugs Revenue by Application
  12. 5.3.1 Global Stem Cell Drugs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Stem Cell Drugs Revenue by Application (2021-2032)
  14. 5.3.3 Global Stem Cell Drugs Revenue Market Share by Application (2021-2032)
6 Global Stem Cell Drugs Sales by Region
  1. 6.1 Global Stem Cell Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Stem Cell Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Stem Cell Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Stem Cell Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Stem Cell Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Stem Cell Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Stem Cell Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Stem Cell Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Stem Cell Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Stem Cell Drugs Revenue by Region
  1. 7.1 Global Stem Cell Drugs Revenue by Region
  2. 7.1.1 Global Stem Cell Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Stem Cell Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Stem Cell Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Stem Cell Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Stem Cell Drugs Revenue (2021-2032)
  8. 7.2.2 North America Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Stem Cell Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Stem Cell Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Stem Cell Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Stem Cell Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Anterogen
  2. 8.1.1 Anterogen Company Information
  3. 8.1.2 Anterogen Business Overview
  4. 8.1.3 Anterogen Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Anterogen Stem Cell Drugs Product Portfolio
  6. 8.1.5 Anterogen Recent Developments
  7. 8.2 Chiesi Pharmaceuticals
  8. 8.2.1 Chiesi Pharmaceuticals Company Information
  9. 8.2.2 Chiesi Pharmaceuticals Business Overview
  10. 8.2.3 Chiesi Pharmaceuticals Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chiesi Pharmaceuticals Stem Cell Drugs Product Portfolio
  12. 8.2.5 Chiesi Pharmaceuticals Recent Developments
  13. 8.3 CORESTEM, Inc
  14. 8.3.1 CORESTEM, Inc Company Information
  15. 8.3.2 CORESTEM, Inc Business Overview
  16. 8.3.3 CORESTEM, Inc Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CORESTEM, Inc Stem Cell Drugs Product Portfolio
  18. 8.3.5 CORESTEM, Inc Recent Developments
  19. 8.4 JCR Pharmaceuticals Co., Ltd
  20. 8.4.1 JCR Pharmaceuticals Co., Ltd Company Information
  21. 8.4.2 JCR Pharmaceuticals Co., Ltd Business Overview
  22. 8.4.3 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Product Portfolio
  24. 8.4.5 JCR Pharmaceuticals Co., Ltd Recent Developments
  25. 8.5 MEDIPOST
  26. 8.5.1 MEDIPOST Company Information
  27. 8.5.2 MEDIPOST Business Overview
  28. 8.5.3 MEDIPOST Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MEDIPOST Stem Cell Drugs Product Portfolio
  30. 8.5.5 MEDIPOST Recent Developments
  31. 8.6 New York Blood Center
  32. 8.6.1 New York Blood Center Company Information
  33. 8.6.2 New York Blood Center Business Overview
  34. 8.6.3 New York Blood Center Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 New York Blood Center Stem Cell Drugs Product Portfolio
  36. 8.6.5 New York Blood Center Recent Developments
  37. 8.7 Pharmicell Co., Ltd
  38. 8.7.1 Pharmicell Co., Ltd Company Information
  39. 8.7.2 Pharmicell Co., Ltd Business Overview
  40. 8.7.3 Pharmicell Co., Ltd Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmicell Co., Ltd Stem Cell Drugs Product Portfolio
  42. 8.7.5 Pharmicell Co., Ltd Recent Developments
  43. 8.8 Takeda
  44. 8.8.1 Takeda Company Information
  45. 8.8.2 Takeda Business Overview
  46. 8.8.3 Takeda Stem Cell Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takeda Stem Cell Drugs Product Portfolio
  48. 8.8.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Stem Cell Drugs Value Chain Analysis
  2. 9.1.1 Stem Cell Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Stem Cell Drugs Production Mode & Process
  6. 9.2 Stem Cell Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Stem Cell Drugs Distributors
  9. 9.2.3 Stem Cell Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst